BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Policy

  Co-Diagnostics Completes Submission of CE Mark Registration for Zika/Dengue/Chikungunya Multiplex Test

  Company’s multiplexed Logix Smart™ ZDC Test to be available for purchase with CE mark in March 2019

  February 26, 2019

   · 

  4 min read
• Pharm Country

  Lannett To Participate At Two Investor Conferences In March

  Lannett Company, Inc. announced its participation at two upcoming investor conferences.

  February 26, 2019

   · 

  1 min read
• Drug Development

  LYNPARZA® (olaparib) Reduced the Risk of Disease Progression or Death as First-Line Maintenance Treatment in Germline BRCA-Mutated Metastatic Pancreatic Cancer

  AstraZeneca and Merck’s LYNPARZA Is the First PARP Inhibitor to Demonstrate Benefit in gBRCAm Metastatic Pancreatic Cancer in a Phase 3 Trial

  February 26, 2019

   · 

  16 min read
• Alkermes Initiates Clinical Study of ALKS 4230 Administered Subcutaneously in Patients With Advanced Solid Tumors

  Once-Weekly and Once-Every-Three-Week Dosing of ALKS 4230 to be Evaluated as Monotherapy and in Combination With Pembrolizumab

  February 26, 2019

   · 

  6 min read
• Business

  Blueprint Medicines Reports Fourth Quarter and Full Year 2018 Financial Results

  Blueprint Medicines Corporation reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2018.

  February 26, 2019

   · 

  11 min read
• Deals

  Fresenius Medical Care completes acquisition of NxStage Medical

  Fresenius Medical Care, the world’s largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc., following approval by antitrust authorities in the United States.

  February 26, 2019

   · 

  4 min read
• Business

  Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership

  New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora’s International Footprint to 24 Countries

  February 26, 2019

   · 

  6 min read
• Policy

  Trio Health Highlights Real World Evidence Outcomes from Studies of HCV, Hemophilia, and HIV

  Research closely parallels FDA’s guidance for incorporating real world evidence into its regulatory oversight

  February 26, 2019

   · 

  5 min read
• Deals

  Aerpio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 5, 2019

  Aerpio Pharmaceuticals, Inc. announced that its fourth quarter and full year 2018 financial results will be released before the market opens on Tuesday, March 5, 2019.

  February 26, 2019

   · 

  2 min read
• Business

  MedVantx Expands its Senior Management Team - Focusing on Sales, Marketing and Business Development

  MedVantx, Inc., the leading provider of ecommerce enabled pharmacy solutions is pleased to announce the continued expansion of its senior leadership team.

  February 26, 2019

   · 

  2 min read